Page last updated: 2024-08-24

tirofiban and Cerebral Infarction, Middle Cerebral Artery

tirofiban has been researched along with Cerebral Infarction, Middle Cerebral Artery in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's5 (45.45)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Hang, Y; Jia, ZY; Liu, S; Ni, H; Shi, HB; Wang, CD; Zhao, LB1
Hu, H; Qian, C; Wang, H; Xu, J1
Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F1
Chen, C; Dai, X; Huang, D; Li, T; Li, X; Pan, T; Qian, Y; Zhao, Y; Zhou, L1
Xiong, W; Yu, YJ1
Barry, DM; Dai, XR; Fan, ML; Hou, SX; Jin, H; Kong, F; Lau, LF; Li, TT; Li, XY; Luo, SY; Zhang, GH; Zhou, LL1
Hwang, YH; Kang, DH; Kim, YS; Kim, YW; Liebeskind, DS1
Jovanovic, V; Junghans, U; Seitz, RJ; Siebler, M; Straub, S; Wittsack, HJ1
Junghans, U; Meisel, S; Moll, M; Seitz, RJ; Siebler, M; Wittsack, HJ1
Aoki, T; Maeda, M; Matsuoka, N; Mihara, K; Moriguchi, A; Mutoh, S1
Cellerini, M; Gensini, G; Inzitari, D; Mangiafico, S; Nencini, P1

Trials

2 trial(s) available for tirofiban and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion.
    Stroke, 2004, Volume: 35, Issue:3

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

2004
The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions.
    Neurology, 2004, Jun-08, Volume: 62, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Brain; Brain Ischemia; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Image Processing, Computer-Assisted; Infarction, Middle Cerebral Artery; Magnesium; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

2004

Other Studies

9 other study(ies) available for tirofiban and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Balloon Angioplasty Combined with Tirofiban as a First-Line Rescue Treatment After Failed Mechanical Thrombectomy for Middle Cerebral Artery Occlusion with Underlying Atherosclerosis.
    World neurosurgery, 2022, Volume: 166

    Topics: Angioplasty; Angioplasty, Balloon; Atherosclerosis; Constriction, Pathologic; Humans; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Thrombectomy; Tirofiban; Treatment Outcome

2022
Perfusion image guided mechanical thrombectomy combined with tirofiban successfully revascularize systemic lupus erythematosus related acute large vessel occlusion: A case report.
    Medicine, 2021, May-07, Volume: 100, Issue:18

    Topics: Adult; Female; Humans; Infarction, Middle Cerebral Artery; Lupus Erythematosus, Systemic; Middle Cerebral Artery; Perfusion Imaging; Thrombectomy; Thrombotic Stroke; Tirofiban; Tomography, X-Ray Computed; Treatment Outcome

2021
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
    World neurosurgery, 2017, Volume: 103

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial

2017
Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property.
    Brain, behavior, and immunity, 2018, Volume: 69

    Topics: Animals; Blood-Brain Barrier; Brain; Crotalid Venoms; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Neurons; Platelet Glycoprotein GPIb-IX Complex; Reperfusion Injury; Tirofiban

2018
Tirofiban combined with rt-PA intraarterial thrombolysis improves the recanalization rate of acute middle cerebral artery occlusion in rabbits.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:9

    Topics: Acute Disease; Animals; Brain Ischemia; Drug Therapy, Combination; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Male; Rabbits; Random Allocation; Recombinant Proteins; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome

2018
A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.
    British journal of pharmacology, 2015, Volume: 172, Issue:15

    Topics: Animals; Bleeding Time; Blood Platelets; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrin; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Platelet Glycoprotein GPIb-IX Complex; Protective Agents; Reperfusion Injury; Stroke; Tirofiban; Tyrosine; von Willebrand Factor

2015
Impact of Target Arterial Residual Stenosis on Outcome After Endovascular Revascularization.
    Stroke, 2016, Volume: 47, Issue:7

    Topics: Aged; Cerebral Angiography; Combined Modality Therapy; Computed Tomography Angiography; Diagnosis, Differential; Endovascular Procedures; Female; Humans; Infarction, Middle Cerebral Artery; Intracranial Arteriosclerosis; Magnetic Resonance Angiography; Male; Middle Aged; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Smoking; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine; Vasospasm, Intracranial

2016
FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2005, Volume: 25, Issue:1

    Topics: Animals; Blood Platelets; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Male; Microcirculation; Neutrophils; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Propionates; Recovery of Function; Reperfusion Injury; Tirofiban; Tyrosine

2005
Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
    Stroke, 2005, Volume: 36, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Catheterization; Combined Modality Therapy; Female; Heparin; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Male; Middle Aged; Risk; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2005